UMass Amherst chemists have developed a three-color fluorescent method to visualize different mRNA molecules inside living ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells—an advance ...
A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...
SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.
MIT and Broad Institute researchers have developed an mRNA approach that temporarily programs liver cells to produce ...
News-Medical.Net on MSN
First-of-its-kind mRNA system switches on therapeutic genes inside targeted cells
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that ...
Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...
A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, Stanford University researchers found, shedding light on a mechanism that’s fueled ...
The World Health Organization (WHO) welcomes a new €8 million, four-year contribution from the Government of Belgium to ...
As people age, their immune system function declines. T cell populations become smaller and can't react to pathogens as ...
Researchers at MIT and the Broad Institute have found a way to overcome age-related immune system decline by temporarily programming cells in the liver to take over a critical immune system function: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results